As Business editor, my aim is to highlight to readers the exciting and innovative chemistry going on in the commercial sector, as well as keeping you abreast of trends and developments in the world of chemistry businesses.
From the point I left school, my aim was to join the pharmaceutical industry. A gap year and summer placements in company labs, and a PhD in organic synthesis followed.
But halfway through my PhD I entered a writing competition run by the Daily Telegraph. I managed to win – somewhat to my own surprise. That changed my perspective and made me think that I should consider writing more seriously as a career. I joined the Royal Society of Chemistry just before submitting my thesis, and luckily a position with Chemistry World came up a few months later. I sometimes miss the thrills (less so the spills) of lab work, but interacting with world-leading scientists and industrialists, as well as learning new things on a daily basis more than makes up for it.
Deals give Fresenius’s entry into rapidly growing biological drugs market
Firms spar over single-molecule gene sequencing technology
Diverse approaches suit different goals
Closures are part of an ongoing reorganisation aimed at increasing productivity
$820m sale of Saudi Arabian plants continues Shell’s global reorganisation programme
Agreement with Forward Pharma gives Biogen license to keep selling blockbuster Tecfidera
Prosecutors allege the men masterminded a kickback scheme between Valeant and the speciality pharmacy